2025-05-24 - Analysis Report
Okay, here's a report analyzing Salesforce Inc. (CRM) based on the provided data.

## Salesforce Inc. (CRM) Analysis Report

**Company Overview:** Salesforce Inc. is a global leader in cloud-based software, providing customer relationship management (CRM) services.

### 1. Performance vs. S&P 500 (VOO)

*   **CRM Cumulative Return:** 30.25%
*   **VOO Cumulative Return:** 79.45%
*   **Absolute Divergence:** -49.2%
*   **Relative Divergence:** 12.8%

**Analysis:** CRM has significantly underperformed the S&P 500 (VOO). The large negative divergence (-49.2%) indicates that VOO has delivered much higher returns during the observed period. The Relative Divergence of 12.8% suggests CRM's underperformance is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
|------------|--------|-------|--------|-------|--------|
| 2015-2017  | 41.0%  | 59.0% | 12.0%  | -0.0 | 97.4   |
| 2016-2018  | 43.0%  | 64.9% | 25.0%  | 0.0   | 130.5  |
| 2017-2019  | 43.0%  | 64.9% | 13.0%  | 0.5   | 154.9  |
| 2018-2020  | 32.0%  | 64.9% | 7.0%   | 0.5   | 212.0  |
| 2019-2021  | 44.0%  | 61.2% | -11.0% | 0.6   | 242.1  |
| 2020-2022  | -93.0% | 69.2% | -99.0% | 0.7   | 126.3  |
| 2021-2023  | -46.0% | 69.2% | -63.0% | 2.0   | 250.7  |
| 2022-2024  | -42.0% | 69.2% | -58.0% | 2.3   | 320.3  |
| 2023-2025  | 26.0%  | 73.5% | -1.0%  | 2.6   | 262.1  |

**Analysis:**

*   **CAGR:**  Fluctuating CAGR, with significant negative returns in 2020-2022 and 2021-2023 periods. Recent recovery in 2023-2025.
*   **MDD:** High Maximum Drawdown (MDD) indicates substantial risk and volatility.
*   **Alpha:**  Negative alpha in recent years suggests underperformance relative to its risk-adjusted benchmark.  Alpha was strong in earlier periods (2015-2019).
*   **Beta:** Beta has increased significantly in recent years, suggesting increased sensitivity to market movements.
*   **Cap(B):** Market capitalization has generally increased over time, though there were declines in some periods.

### 2. Recent Price Action

*   **Current Price:** 273.13
*   **Previous Close:** 283.42
*   **Change:** -3.63
*   **5-day Moving Average:** 282.90
*   **20-day Moving Average:** 279.55
*   **60-day Moving Average:** 272.40

**Analysis:** CRM's price is currently below its 5-day and 20-day moving averages, indicating short-term bearish momentum. The price is slightly above the 60-day moving average. The recent negative change (-3.63) from the previous close suggests a significant recent decline.

### 3. Market Risk Indicators and Expected Return

*   **MRI:** 0.365 (Low Risk)
*   **RSI:** 50.52 (Neutral)
*   **PPO:** -0.24 (Slightly Bearish)
*   **Recent Relative Divergence Change (20-day):** -2.5 (Short-term decline)
*   **Expected Return:** -235.4%

**Analysis:**

*   The Market Risk Indicator (MRI) is in the "Low Risk" range.
*   The RSI is near neutral, indicating neither overbought nor oversold conditions.
*   The PPO is slightly negative, suggesting a potential downtrend.
*   The decreasing relative divergence suggests recent underperformance relative to its benchmark.
*   The very negative Expected Return (-235.4%) indicates a highly pessimistic long-term outlook compared to the S&P 500.  **This is a critical concern.** The large negative *change* from the previous day suggests a short-term drop.

### 4. Recent News & Significant Events

*   **[2025-05-21]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-22]:** Analyst discussions about recent performance, industry trends, and global economic factors.
*   **[2025-05-24]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-20]:** Market experts highlight both risks and opportunities, advising investors to monitor news and announcements.

**Analysis:** The news indicates that CRM is experiencing notable volatility and is subject to market scrutiny due to significant events and analyst discussions. This suggests heightened uncertainty surrounding the company's future performance.

### 5. Recent Earnings Analysis:

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2024-12-04 | 1.6  | 9.44 B$    |
| 2024-08-29 | 1.48 | 9.32 B$    |
| 2024-05-30 | 1.58 | 9.13 B$    |
| 2023-11-30 | 1.26 | 8.72 B$    |
| 2024-12-04 | 1.26 | 8.72 B$    |

**Analysis:**

*   **EPS:** EPS has generally increased over the last few quarters, indicating improving profitability.
*   **Revenue:** Revenue has also shown consistent growth, suggesting healthy business expansion.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-01-31 | $9.99B    | 77.81%        |
| 2024-10-31 | $9.44B    | 77.71%        |
| 2024-07-31 | $9.32B    | 76.85%        |
| 2024-04-30 | $9.13B    | 76.33%        |
| 2024-01-31 | $9.29B    | 76.87%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-01-31 | $61.17B   | 2.79%    |
| 2024-10-31 | $58.52B   | 2.61%    |
| 2024-07-31 | $57.63B   | 2.48%    |
| 2024-04-30 | $59.68B   | 2.57%    |
| 2024-01-31 | $59.65B   | 2.42%    |

**Analysis:**

*   **Revenue & Profit Margin:** Revenue is consistently growing, and profit margins are exceptionally high and stable, indicating strong business operations.
*   **Equity & ROE:** Equity has generally increased, reflecting growing shareholder value. ROE has also slightly improved, though it remains relatively modest.

### 7. Overall Analysis & Conclusion

CRM's recent performance is concerning. While the company demonstrates strong revenue growth and profitability, its stock has significantly underperformed the S&P 500.  The high and increasing beta indicates that the stock may be becoming more sensitive to overall market risk.

*   **Strengths:** Strong revenue growth, high profit margins, and increasing equity.
*   **Weaknesses:** Significant underperformance compared to the S&P 500, negative alpha in recent periods, and a very negative expected return. High volatility and market sensitivity.

**Recommendation:** Given the significant underperformance, negative expected return, and recent volatility, investors should exercise caution.  A deeper investigation into the reasons for the underperformance and the factors driving the negative expected return is strongly recommended. Monitoring upcoming earnings reports and company announcements is crucial.
